Skip to main content
. Author manuscript; available in PMC: 2017 Aug 8.
Published in final edited form as: Obstet Gynecol Surv. 2016 Aug;71(8):477–487. doi: 10.1097/OGX.0000000000000342

Table 1. Comparison of Prenatal Screening Options1,2831.

cfDNA Screening First Trimester Screening Second Trimester Screening (Quad Screen) Integrated Screen (NT, PAPP-A, Quad Screen)
Gestational age >10 wk 11–14 wk 15–24 wk PAPP-A: 9–13 wk
NT: 10–13 wk
Quad screen: 15–24 wk
Detection rate
 Trisomy 21 99.2 82–87 81 94–96*
 Trisomy 18 96.3 81 60 90
 Trisomy 13 91.0 Limited data N/A Limited data
*

Detection rate for trisomy 21 of a fully integrated screen that includes a nuchal translucency measurement.

Detection rate of trisomy 18 of a serum integrated screen.

NT indicates nuchal translucency; N/A, not applicable.